Sp464

DIET AND MICROBIOME-BASED THERAPIES FOR IBD - WHAT ARE THE DATA?

Date
May 7, 2023
Explore related products in the following collection:

Society: AGA

In the last five years, there have been three distinct small molecules that have been approved for the management of ulcerative colitis. This session will review the efficacy, safety and practical applications for use of these agents in the management of ulcerative colitis and examine their role in Crohn’s disease. . It will also examine the current role of non-targeted small molecules (thiopurines and methotrexate), diet, and microbiome-directed therapies in the treatment of IBD.

Presenter

Speaker Image for Ashwin Ananthakrishnan
Massachusetts General Hospital

Tracks

Related Products

Thumbnail for EMPIRIC DIETARY INFLAMMATORY PATTERN (EDIP) IS INVERSELY ASSOCIATED WITH RISK OF MICROSCOPIC COLITIS
EMPIRIC DIETARY INFLAMMATORY PATTERN (EDIP) IS INVERSELY ASSOCIATED WITH RISK OF MICROSCOPIC COLITIS
BACKGROUND The gut microbiome is central to Crohn’s disease (CD) pathogenesis but the relative contribution of different environmental factors to disease compositional variation is unknown…
Thumbnail for THE SULFUR MICROBIAL DIET AND RISK OF INFLAMMATORY BOWEL DISEASE
THE SULFUR MICROBIAL DIET AND RISK OF INFLAMMATORY BOWEL DISEASE
BACKGROUND The gut microbiome is central to Crohn’s disease (CD) pathogenesis but the relative contribution of different environmental factors to disease compositional variation is unknown…
Thumbnail for PANEL DISCUSSION
PANEL DISCUSSION
In the last five years, there have been three distinct small molecules that have been approved for the management of ulcerative colitis…
Thumbnail for AGA GUIDELINE Q&A: BIOMARKERS FOR MONITORING INFLAMMATION IN IBD
AGA GUIDELINE Q&A: BIOMARKERS FOR MONITORING INFLAMMATION IN IBD
AGA guidelines are among the most rigorously evidence-based and trusted guidelines in the field of GI and hepatology…